PSMD14
Basic information
Region (hg38): 2:161308425-161411717
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PSMD14 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 4 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 4 | 0 | 0 |
Variants in PSMD14
This is a list of pathogenic ClinVar variants found in the PSMD14 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-161367778-C-A | Benign (May 26, 2018) | |||
2-161391140-A-G | not specified | Uncertain significance (Dec 14, 2021) | ||
2-161391156-G-A | not specified | Uncertain significance (Jan 31, 2024) | ||
2-161395199-A-G | not specified | Uncertain significance (Nov 07, 2022) | ||
2-161411389-G-A | not specified | Uncertain significance (Jun 21, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PSMD14 | protein_coding | protein_coding | ENST00000409682 | 10 | 103680 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.977 | 0.0234 | 124563 | 0 | 2 | 124565 | 0.00000803 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.57 | 29 | 153 | 0.189 | 0.00000735 | 2035 |
Missense in Polyphen | 10 | 69.51 | 0.14386 | 901 | ||
Synonymous | 1.46 | 37 | 50.1 | 0.738 | 0.00000247 | 550 |
Loss of Function | 3.47 | 1 | 15.9 | 0.0627 | 6.76e-7 | 234 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000291 | 0.0000291 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000886 | 0.00000885 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. The PSMD14 subunit is a metalloprotease that specifically cleaves 'Lys-63'-linked polyubiquitin chains within the complex. Plays a role in response to double-strand breaks (DSBs): acts as a regulator of non- homologous end joining (NHEJ) by cleaving 'Lys-63'-linked polyubiquitin, thereby promoting retention of JMJD2A/KDM4A on chromatin and restricting TP53BP1 accumulation. Also involved in homologous recombination repair by promoting RAD51 loading. {ECO:0000269|PubMed:1317798, ECO:0000269|PubMed:22909820, ECO:0000269|PubMed:9374539}.;
- Pathway
- Epstein-Barr virus infection - Homo sapiens (human);Proteasome - Homo sapiens (human);Parkin-Ubiquitin Proteasomal System pathway;Neutrophil degranulation;proteasome complex;Post-translational protein modification;Metabolism of proteins;Innate Immune System;Immune System;Metalloprotease DUBs;UCH proteinases;Neddylation;Ub-specific processing proteases;Deubiquitination
(Consensus)
Recessive Scores
- pRec
- 0.281
Intolerance Scores
- loftool
- 0.369
- rvis_EVS
- 0.01
- rvis_percentile_EVS
- 54.63
Haploinsufficiency Scores
- pHI
- 0.967
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.684
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.903
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Low | Low |
Primary Immunodeficiency | Medium | Low | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Psmd14
- Phenotype
Gene ontology
- Biological process
- double-strand break repair via homologous recombination;double-strand break repair via nonhomologous end joining;ubiquitin-dependent protein catabolic process;positive regulation of endopeptidase activity;protein deubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;neutrophil degranulation;post-translational protein modification;response to ethanol;regulation of proteasomal protein catabolic process;protein K63-linked deubiquitination
- Cellular component
- proteasome complex;extracellular region;nucleus;nucleoplasm;cytosol;proteasome regulatory particle, lid subcomplex;proteasome accessory complex;cytosolic proteasome complex;secretory granule lumen;ficolin-1-rich granule lumen
- Molecular function
- thiol-dependent ubiquitin-specific protease activity;protein binding;metallopeptidase activity;thiol-dependent ubiquitinyl hydrolase activity;metal ion binding;endopeptidase activator activity;Lys63-specific deubiquitinase activity;proteasome binding